Here is the literal biology: GHK-Cu activates Wnt/beta-catenin signaling to restart dormant follicles, suppresses TGF-beta1 to prevent premature regression, stimulates VEGF for perifollicular blood supply, and protects dermal papilla cells from programmed death (Pickart & Margolina, 2018)
Important safety considerations include a boxed warning for medullary thyroid carcinoma risk, monitoring for pancreatitis (severe abdominal pain), gallbladder disease, and potential hypoglycemia when used with insulin or sulfonylureas
Gut dysbiosis is strongly associated with the development of ACM (16)
As of July 1, 2025, CVS Caremark selected Wegovy as its preferred weight loss medication, removing Zepbound from most formularies
The good news is that the body can get used to the medication
Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: An immunocytochemical study